DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Glund S, Moschetti V, Norris S. et al.
A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran.
Thromb Haemost 2015;
113: 943-951.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.